My passion is oncology research. I have been and continue to be actively involved in clinical trials through the National Cancer Institute and various pharmaceutical companies. As a nurse practitioner, my clinical practice is specific to the care of patients participating in phase I clinical trials.
I have a specific interest in biomarker research. The incorporation of biomarkers in oncology clinical trials has been an important advancement in research, and we’ve seen the effect on improving patient outcomes. Identification of pathogenic variants is essential to prescribing personalized therapy for patients with cancer.
My research shows that we must focus on increasing biomarker awareness among oncology nurses. In my research program, I’ve been a part of creating educational tools and resources to help nurses understand clinical biomarkers and how to integrate that knowledge into practice. As a previous associate editor for the
Clinical Journal of Oncology Nursing
’s Evolving Foundations department, I have helped nurse writers publish peer education about molecular testing, predictive and diagnostic biomarkers, targeted therapies, and personalized medicine to keep oncology nurse colleagues up to date.
My passion is oncology research. I have been and continue to be actively involved in clinical trials through the National Cancer Institute and various pharmaceutical companies. As a nurse practitioner, my clinical practice is specific to the care of patients participating in phase I clinical trials.
I have a specific interest in biomarker research. The incorporation of biomarkers in oncology clinical trials has been an important advancement in research, and we’ve seen the effect on improving patient outcomes. Identification of pathogenic variants is essential to prescribing personalized therapy for patients with cancer.
My research shows that we must focus on increasing biomarker awareness among oncology nurses. In my research program, I’ve been a part of creating educational tools and resources to help nurses understand clinical biomarkers and how to integrate that knowledge into practice. As a previous associate editor for the
Clinical Journal of Oncology Nursing
’s Evolving Foundations department, I have helped nurse writers publish peer education about molecular testing, predictive and diagnostic biomarkers, targeted therapies, and personalized medicine to keep oncology nurse colleagues up to date.